Iridex (IRIX) Interest & Investment Income (2010 - 2011)

Iridex (IRIX) posted Interest & Investment Income of -$64000.0 for Q4 2011, up 51.15% on a QoQ basis from -$131000.0 in Q4 2011.

Analysis

Iridex (IRIX) Interest & Investment Income (2010 - 2011) Analysis & Trends

Iridex has reported Interest & Investment Income for 2 years, with the latest figure at -$64000.0 in Q4 2011.

On a quarterly basis, Interest & Investment Income changed N/A year-over-year to -$64000.0 in Q4 2011; TTM through Dec 2011 was -$285000.0, a N/A change from a year earlier, with the FY2026 full-year figure at $324000.0, changed N/A from the prior year.
Interest & Investment Income was -$64000.0 for Q4 2011 at Iridex, up from -$131000.0 in the prior quarter.
The five-year high for Interest & Investment Income was $63000.0 in Q4 2010, with the low at -$153000.0 in Q3 2011.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	52.00 Mn
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	-
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	-
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	-
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	-
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	30.00 Mn
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	-
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	-
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	-
10	Iridex	11.85 Mn	7.17 Mn	4.30 Mn	-

Historic Data

Download Data